肠道微生物胆汁和氨基酸代谢与花生口服免疫疗法失败有关

Mustafa Özçam1, Din L Lin1, Chhedi L Gupta1,2,3

  • 1Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

PubMed
概括

肠道微生物的代谢能力预测花生口服免疫疗法 (POIT) 的成功. 便样本中的特定胆酸和细菌基因,如ptpA,可能表明花生过敏儿童的治疗失败.